Cargando…

Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin

Lanthionine-containing peptides (lantibiotics) have been considered as pharmaceutical candidates for decades, although their clinical application has been restricted. Most lantibiotics kill bacteria via targeting and segregating of the cell wall precursor—membrane-inserted lipid II molecule—in some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panina, Irina, Taldaev, Amir, Efremov, Roman, Chugunov, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538299/ https://www.ncbi.nlm.nih.gov/pubmed/34683220 http://dx.doi.org/10.3390/mi12101169

Ejemplares similares

Environmental and dynamic effects explain how nisin captures membrane-bound lipid II
por: Panina, Irina, et al.
Publicado: (2020)

Lipid-II forms potential “landing terrain” for lantibiotics in simulated bacterial membrane
por: Chugunov, Anton, et al.
Publicado: (2013)

Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity
por: Panina, Irina S., et al.
Publicado: (2023)

The Mechanism of Selective Recognition of Lipid Substrate by hDHHC20 Enzyme
por: Panina, Irina S., et al.
Publicado: (2022)

Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B
por: Dickman, Rachael, et al.
Publicado: (2019)

Incorporation of tryptophan analogues into the lantibiotic nisin
por: Zhou, Liang, et al.
Publicado: (2016)

The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria‐induced proinflammatory responses in dermal fibroblasts
por: Bengtsson, Torbjörn, et al.
Publicado: (2018)

The antiplaque efficacy of lantibiotic Nisin extract mouthrinse
por: Mitra, Dipika, et al.
Publicado: (2019)

First evidence of production of the lantibiotic nisin P
por: Garcia-Gutierrez, Enriqueta, et al.
Publicado: (2020)

Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae
por: Khosa, Sakshi, et al.
Publicado: (2016)

Molecular Dynamics of DHHC20 Acyltransferase Suggests Principles of Lipid and Protein Substrate Selectivity
por: Panina, Irina, et al.
Publicado: (2022)

Mechanism of Inhibition of Bacillus anthracis Spore Outgrowth by the Lantibiotic Nisin
por: Gut, Ian M., et al.
Publicado: (2011)

Systematic characterization of position one variants within the lantibiotic nisin
por: Lagedroste, Marcel, et al.
Publicado: (2019)

Lantibiotic Immunity: Inhibition of Nisin Mediated Pore Formation by NisI
por: AlKhatib, Zainab, et al.
Publicado: (2014)

Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy
por: Chernyshova, Dayana N., et al.
Publicado: (2022)

The Anti-Adhesion Effect of Nisin as a Robust Lantibiotic on the Colorectal Cancer Cells
por: Soleimanifar, Hesam, et al.
Publicado: (2023)

Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria
por: Vukomanović, Marija, et al.
Publicado: (2017)

Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process
por: Weixler, Dominik, et al.
Publicado: (2022)

Correction to: Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two‑step process
por: Weixler, Dominik, et al.
Publicado: (2022)

Protein Defense Systems against the Lantibiotic Nisin: Function of the Immunity Protein NisI and the Resistance Protein NSR
por: Khosa, Sakshi, et al.
Publicado: (2016)

Complete sequences of epidermin and nukacin encoding plasmids from oral-derived Staphylococcus epidermidis and their antibacterial activity
por: Nakazono, Kenta, et al.
Publicado: (2022)

A Chemical Biology Approach to Understanding Molecular Recognition of Lipid II by Nisin(1–12): Synthesis and NMR Ensemble Analysis of Nisin(1–12) and Analogues
por: Dickman, Rachael, et al.
Publicado: (2019)

Insights in the Antimicrobial Potential of the Natural Nisin Variant Nisin H
por: Reiners, Jens, et al.
Publicado: (2020)

Docking and molecular dynamics simulations of the ternary complex nisin(2):lipid II
por: Mulholland, Sam, et al.
Publicado: (2016)

Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling
por: Taldaev, Amir, et al.
Publicado: (2022)

Insights into the Mode of Action of the Two-Peptide Lantibiotic Haloduracin
por: Oman, Trent J., et al.
Publicado: (2009)

New insights into the mode of action of the lantibiotic salivaricin B
por: Barbour, Abdelahhad, et al.
Publicado: (2016)

Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius
por: Wescombe, Philip A., et al.
Publicado: (2012)

The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
por: Fujinami, Daisuke, et al.
Publicado: (2018)

Insight into Two ABC Transporter Families Involved in Lantibiotic Resistance
por: Clemens, Rebecca, et al.
Publicado: (2018)

Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization
por: Prince, Ashutosh, et al.
Publicado: (2016)

Bioengineering Lantibiotics for Therapeutic Success
por: Field, Des, et al.
Publicado: (2015)

Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus
por: Biswas, Saswati
Publicado: (2023)

Bovicin HJ50-Like Lantibiotics, a Novel Subgroup of Lantibiotics Featured by an Indispensable Disulfide Bridge
por: Wang, Jian, et al.
Publicado: (2014)

Corrigendum: Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization
por: Prince, Ashutosh, et al.
Publicado: (2017)

Structure, dynamics and kinetics of two-component Lantibiotic Lichenicidin
por: de Miguel, Alejandra, et al.
Publicado: (2017)

Liquid but Durable: Molecular Dynamics Simulations Explain the Unique Properties of Archaeal-Like Membranes
por: Chugunov, Anton O., et al.
Publicado: (2014)

Sublancin is not a lantibiotic but an S-linked glycopeptide
por: Oman, Trent J., et al.
Publicado: (2011)

Elucidation of the Bridging Pattern of the Lantibiotic Pseudomycoicidin
por: Janssen, Kathrin, et al.
Publicado: (2022)

An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium
por: Zhao, Xinghong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jeejvmipocn9usq2s1nba83lrd